Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated August 12, 2019 for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) of the Company for the Quarter ended June 30, 2019 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of Extract of Statement of aforesaid Unaudited Financial Results published in the following newspapers on August 13, 2019:- Business Standard (English); Desh Sewak (Punjabi)
14-08-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Fixes Book Closure for AGM

 Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2019 to September 30, 2019 (both days inclusive) for the purpose of 35th Annual General Meeting (AGM) of the Company to be held on September 30, 2019.
14-08-2019
Bigul

Panacea Biotec Ltd - 531349 - Clarification sought from Panacea Biotec Ltd

 The Exchange has sought clarification from Panacea Biotec Ltd on August 13, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
13-08-2019
Bigul

Panacea Biotec Ltd - 531349 - Outcome of Board Meeting (EGM on Sept 10, 2019)

 Panacea Biotec Ltd has informed BSE about Outcome of Board Meeting held on August 12, 2019.
12-08-2019
Bigul

PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30, 2019

 In continuation to our letter dated July 31, 2019 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations"), we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. August 12, 2019, inter-alia, considered and approved the Standalone and Consolidated Unaudited Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2019. The same were also reviewed by the Audit Committee in its meeting held earlier on August 12, 2019. A copy of the same along with the Limited Review Report is enclosed.
12-08-2019
Bigul

Panacea Biotec Ltd - 531349 - Outcome of Board Meeting

 In continuation to our letter dated July 31, 2019 and pursuant to Reg. 30 and 33 of SEBI LODR Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. 12.08.19, inter-alia, considered and approved the Standalone and Consolidated Unaudited Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended 30.06.2019. The same were also reviewed by the Audit Committee in its meeting held earlier on 12.08.19. A copy of the same along with the Limited Review Report is enclosed herewith.
12-08-2019
Bigul

Panacea Biotec Ltd - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, the data of shares dematerialized during the month of July, 2019 is being submitted.
08-08-2019
Bigul

Panacea Biotec Ltd - 531349 - Closure of Trading Window

 We would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till August 14, 2019.
31-07-2019
Bigul

Panacea Biotec Ltd - 531349 - Board Meeting Intimation for For Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30, 2019

 PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2019. Further, with reference to our earlier announcement dated March 29, 2019 intimating the Closure of Trading Window pursuant to the Company's Code of Conduct for Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till August 14, 2019.
31-07-2019
Bigul

Panacea Biotec Ltd - 531349 - Shareholding for the Period Ended June 30, 2019

 Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here
22-07-2019
Next Page
Close

Let's Open Free Demat Account